Picture of Skinbiotherapeutics logo

SBTX — Skinbiotherapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: SkinBioTherapeutics Announces Positive Interim AxisBiotix Acne study Data

Feb 27 (Reuters) - SkinBioTherapeutics PLC  SBTX.L :
    * INTERIM DATA FROM AXISBIOTIX ACNE FOOD SUPPLEMENT CONSUMER
PARTICIPANT STUDY WITH LEAD FORMULATION ARE VERY POSITIVE
    * AXISBIOTIX ACNE FOOD SUPPLEMENT CONSUMER PARTICIPANT STUDY
FINAL
RESULTS IS ANTICIPATED TO OCCUR BEFORE END OF Q1 2024

Source text for Eikon:  ID:nRSa5861Ea 
Further company coverage:  SBTX.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Skinbiotherapeutics

See all news